Therapeutic approaches to anaphylaxis such as adrenaline as first-line treatment, glucagon as second-line treatment, and anti-histamines as third-line treatment have long been attempted and developed; however, there are still unmet therapeutic needs for anaphylaxis (Tanno et al., 2019). This evidence concerns the gene GCG and anaphylaxis.